top of page

EVERYTHING IoT

Healthcare & Wellbeing Forum 2019

Showcasing Australia's Healthcare Innovation

EVERYTHING_IOT_health_4.png

ABOUT THE FORUM

Australia’s healthcare system is considered to be one of the best in the world, but pressures driven by an ageing population and increasing demand for specialised care is causing costs to rise unsustainably faster than economic growth. IoT connectivity has been identified to increase productivity, efficiency, and precision in the healthcare and wellbeing sector, with outstanding economic benefits. Together, our world-class healthcare system and digital innovation place Australia in a competitive advantage to revolutionise healthcare on a global scale.

Everything IoT’s Healthcare & Wellbeing Forum provides an in-depth examination of the state of Healthcare in Australia from a global perspective, drawing upon the professional experiences of keynote speakers and panellists. At this event, you can expect an all-rounded representation of entrepreneurs, corporate executives, Government bodies, researchers, and investors who are actively engaged with the future of health and wellbeing.

​

AGENDA

Registration

17.00 - 17.30 Registrations, Networking, Food & Drinks

 

Introduction

17.30 - 17.45 Welcome

 

Eitan Bienstock, Founder Everything IoT - Welcome and Industry Update

 

Startup Showcasing 

17.45 - 18.45 Healthcare & Wellbeing startup founder showcase presentations

​

Amy O’Connor,  Soldier.ly - Empathic technologies to combat chronic stress and PTSD

 

Danielle Owen Whitford,  Pioneera - Creating workplaces where we can all be great

 

Rajesh Kumar,  ImmersifAI - Immersive VR tools to better visualise MRI scans

 

Neeraj Kothari,  Cogniant.co - Sensors for early prediction of mental health conditions

​

​

Break 

18.45 - 19.15 Networking, Food & Drinks

​

Startup Showcasing 

19.15 - 20.15 Healthcare & Wellbeing startup founder showcase presentations

​

Seaton McKeon,  Ikkiworks - Companion robots that deliver adjunct therapy

 

Katja Beitat,  Clinivid - Telehealth platform providing intuitive information-sharing

 

Silvia Pfeiffer,  Coviu - AI-driven telehealth solutions for clinicians by clinicians

 

Laura Simmons,  Theratrak - Empowering clinicians and clients through connectivity

​

​

Panel Discussion and Closing Remarks

20.15 - 21.00 Challenges and opportunities for Australian startups going global

​

Moderator: Eitan Bienstock, Founder Everything IoT

​

Kelly Constable, Co-Founder and CEO of AULUS Partners

​

Mike Zimmerman, Partner Main Sequence Ventures

​

Melissa Tate, Professor of Biomedical Engineering University of New South Wales

​

Ian Manovel, Innovation Principal Director for Health at Accenture Australia

​

Networking, Food & Drinks

21.00 - 21.30

KEYNOTE SPEAKERS AND PANELLISTS

Eitan Bienstock Headshot 6.jpg
Kelly Constable Phote.jpg

Eitan Bienstock

Managing Director, Sigma Ventures and Founder, Everything IoT

Entrepreneur, investor and startup mentor, Eitan spent the past 20 years working for fortune 100 companies, venture capital firms and founding couple of startups in Israel, the US and Australia. During the late 90’s Eitan was responsible for the development of Intel Israel’s incubator program, which resulted in over USD100M increase in sales for supported companies in the first 3 years of the program including a successful listing on NASDAQ of (NVMI). After selling his events hire and online marketing companies in 2013, Eitan joined Artesian Capital as a managing director, corporate venturing. Currently, Eitan is the founder of Everything IoT, managing director at Sigma Ventures and a non-executive director of the Spark Festival.

Kelly Constable

Co-Founder and CEO of AULUS Partners

Kelly serves as Head of Strategy and Global Development for the Australia Genomic Cancer Centre. She currently serves as an expert advisor to the NSW Med Tech Fund, Board Member for ANDHealth and Prota Therapeutics. 

 

Kelly is a business executive with 20+ years of life science experience in pharma/biotech industry, including 8 years leading the commercialization of breakthrough digital health platforms to leverage data and analytics in healthcare in the US and EU.  Kelly is passionate about improving outcomes for patients, leading transformative tech in healthcare and driving value for investors.

2019 1_edited.jpg

Mike Zimmerman

Partner at Main Sequence Ventures

Mike is a Partner with Main Sequence Ventures, a new VC firm backed by the Australian Federal Government, CSIRO and other investors to back in deep tech companies commercialising world-leading research.   He has over 20 years of startup operating and investing experience in both Australia and the US, working with companies as an advisor, director and/or investor. Mike has an MBA from Stanford University and a BA from Amherst College. 

MKTphotoSmall_edited.png

Melissa Knothe Tate

Prof. of Biomedical Engineering at University of New South Wales 

Melissa  is the Inaugural Paul Trainor Chair and Professor of Biomedical Engineering at University of New South Wales. She is a global thought leader in healthcare innovation. Her R&D program is epitomized by its cross-cutting nature, where the fundamental laws of mechanics are applied to bio-logical/medical systems to elucidate and emulate emergent and smart properties. Knothe Tate is the recipient of more than 40 honours/awards including Engineers Australia Most Innovative Engineers, the Christopher Columbus Foundation - U.S. Chamber of Commerce Chairman's Distinguished Life Sciences Award, the Alexander von Humboldt Foundation Senior Research Fellowship, and ETH Zurich's Dipl. Ing. Georg Fischer Prize 1998 for most outstanding dissertation, across all departments of the university. She holds three U.S. patents and ten foreign patents that have been licensed to three companies. She is the founder of a consulting company and three startup companies. She has published over 100 peer reviewed articles. Her R&D group, the MechBio Team, has been supported through over $21M in international, national, regional, foundational and industry grants.

Ian Manovel low res.jpg

Ian Manovel

Innovation Principal Director for Health at Accenture Australia

Ian is the Innovation Principal Director for Health at Accenture Australia. In this role he focuses on using innovation and thought leadership to drive change in health systems, to enhance productivity and improve health outcomes for patients. He has 25 years of health experience working across ANZ and Europe supporting transformational programs that deliver growth to health clients. He is a frequent speaker on digital health innovation, entrepreneurship, AI and health system funding. He attended Monash University, The University of London and Imperial College.  

 FORUM PARTNERS

logo_v3.png
Stone and Chalk.jpg
IMG_4283.png
bottom of page